The healthcare sector faces both great change and opportunity.

Rapid innovation in health technology is creating new ways to assist patients, along with new challenges for regulators and industry participants.

Our clients are reimagining the delivery of services across the healthcare sector and we are working with them to navigate industry trends and meet the challenges ahead of them.

How we can help

Allens is at the forefront of developments in the rapidly changing environment, encompassing life sciences. In particular, those developments have applications in the healthcare, pharmaceutical and food-science industries. 

Creating a holistic and commercial strategy

We help leading businesses across healthcare services, pharmaceuticals and medical devices to manage transactions, investments and disputes, looking not only at the regulatory obligations but also product liability, litigation, mergers and acquisitions, privacy, intellectual property, infrastructure, real estate, environment and planning, and funds management.

At the forefront of horizon issues in eHealth

We're working with clients to advise across regulatory compliance, data use, software development/licensing and data protection, including developing new data insight offerings and cloud solutions.

A presence where it's needed the most

We maintain a network of specialist healthcare regulatory and compliance lawyers in key global jurisdictions to assist our clients in dealing with local legislative regimes – wherever they do business.



Advising on COVID-19 vaccine supply arrangements with the Commonwealth of Australia and manufacturing arrangements with CSL.


Allens advised Healthscope on the negotiation of its arrangements with the Federal Government and each State and Territory Government under the National Partnership Agreement as part of Australia's response to COVID-19. The partnership agreement saw Healthscope's private hospital facilities and staff made available to deal with the COVID-19 pandemic in the public health system.

BGH Capital Services Ltd (BGH)

Advised on the acquisition of Healius' medical and dental centre business and its separation from Healius' day hospitals and IVF clinics business.

Healthscope M&A and merger control

Acted for one of Australia's leading private healthcare operators on the $105 million sale of its Australian pathology operations to Crescent Capital Partners.

Mundipharma patent dispute

Successfully defended a challenge to the patent term extension for oxycontin.

Pfizer competition

Acted in proceedings commenced by the ACCC for alleged misuse of market power and exclusive dealing in relation to the supply of atorvastatin to pharmacies.

Compliance and regulatory

Pre- and post-acquisition reviews of marketing authorisations/drug approvals, labelling and promotional compliance and development of strategies to resolve non-compliance.

Plenary Health Consortium bid

Advised the consortium on its bid to finance, design, construct and maintain the new main hospital building and community health facilities at the Royal North Shore Hospital.

Medical Devices

Advising in relation to the regulatory aspects associated with marketing and patient support programs for therapeutic goods, including compliance with industry codes and ethical obligations.